Fresenius Medical Financials

0H9X Stock   43.08  1.57  3.78%   
Financial data analysis helps to check if markets are presently mispricing Fresenius Medical Care. We are able to interpolate and collect twenty available fundamental indicators for Fresenius Medical Care, which can be compared to its peers. The stock experiences an unexpected upward trend. Watch out for market signals. Check odds of Fresenius Medical to be traded at 51.7 in 90 days. Key indicators impacting Fresenius Medical's financial strength include:
Current ValueLast YearChange From Last Year 10 Year Trend
Operating IncomeB2.1 B
Sufficiently Down
Slightly volatile
  
Understanding current and past Fresenius Medical Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Fresenius Medical's financial statements are interrelated, with each one affecting the others. For example, an increase in Fresenius Medical's assets may result in an increase in income on the income statement.
Please note, the imprecision that can be found in Fresenius Medical's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Fresenius Medical Care. Check Fresenius Medical's Beneish M Score to see the likelihood of Fresenius Medical's management manipulating its earnings.

Fresenius Medical Stock Summary

Fresenius Medical competes with Samsung Electronics, Samsung Electronics, Hyundai, Toyota, and State Bank. Fresenius Medical is entity of United Kingdom. It is traded as Stock on LSE exchange.
Specialization
Industrials, Commercial & Professional Services
InstrumentUK Stock View All
ExchangeLondon Exchange
ISINDE0005785802
Business AddressElse-KrOener-Strasse 1, Bad
SectorCommercial Services & Supplies
IndustryIndustrials
BenchmarkDow Jones Industrial
Websitewww.freseniusmedicalcare.com
Phone49 6172 609 0
You should never invest in Fresenius Medical without having analyzed its financial statements. Do not rely on someone else's analysis or guesses about the future performance of Fresenius Stock, because this is throwing your money away. Analyzing the key information contained in Fresenius Medical's financial statements can give you an edge over other investors and help to ensure that your investments perform well for you.

Fresenius Medical Key Financial Ratios

There are many critical financial ratios that Fresenius Medical's investors are exposed to on a daily basis, but they are usually grouped into few meaningful categories from each financial statement that Fresenius Medical Care reports annually and quarterly.

Fresenius Medical Key Balance Sheet Accounts

201920202021202220232024 (projected)
Total Assets24.0B26.2B32.9B31.7B36.4B30.9B
Retained Earnings9.5B10.3B10.8B10.7B12.3B9.9B
Cash358.0M1.3B239.0M334.7M384.9M503.2M
Other Assets1.1B1.1B1.2B1.1B1.3B1.1B
Long Term Debt5.8B5.0B6.5B6.8B7.8B6.8B
Net Receivables4.0B3.6B3.9B4.0B4.6B4.1B
Good Will12.1B12.2B14.0B13.0B14.9B14.1B
Capital Surpluse4.0B3.9B3.6B2.9B2.6B2.9B
Inventory1.7B1.9B2.0B2.3B2.6B1.9B
Other Current Assets306.6M462.2M346.3M370.8M426.5M361.6M
Total Liab14.2B14.5B21.0B20.5B23.5B18.8B
Total Current Assets7.2B7.3B8.0B8.2B9.4B8.1B
Short Term Debt769.3M1.4B1.2B79.3M71.3M67.8M
Intangible Assets683.1M681.3M1.4B1.4B1.6B1.1B
Common Stock304.4M292.9M293.0M293.4M264.1M240.8M
Other Current Liab1.8B2.4B2.6B2.3B2.7B2.4B
Other Liab2.1B2.6B2.4B2.7B3.1B2.6B
Net Tangible Assets(3.5B)(3.1B)(3.1B)(3.3B)(3.0B)(3.1B)
Accounts Payable756.2M794.9M818.5M892.6M1.0B872.3M

Fresenius Medical Key Income Statement Accounts

201920202021202220232024 (projected)
Tax Provision443.1M511.1M401.6M500.6M450.5M397.1M
Interest Income364.8M301.1M429.4M368.0M423.2M401.9M
Selling General Administrative3.3B2.7B2.9B3.2B2.9B2.4B
Total Revenue17.8B16.5B17.5B17.9B20.5B19.0B
Gross Profit6.0B5.2B5.4B5.5B5.0B4.4B
Operating Income2.4B3.0B2.3B2.3B2.1B2.0B
Cost Of Revenue11.8B11.4B12.1B12.3B14.2B12.9B
Income Before Tax2.0B2.7B1.8B1.9B1.7B1.7B
Net Income Applicable To Common Shares1.2B1.2B969.3M673.4M606.1M961.4M
Net Income1.3B2.0B1.2B1.2B1.0B1.1B
Ebit2.3B2.4B1.8B1.6B1.4B1.6B
Income Tax Expense401.6M500.6M352.8M325.0M292.5M334.6M

Fresenius Medical Key Cash Accounts

201920202021202220232024 (projected)
Change In Cash(1.1B)73.8M400.1M(207.9M)(187.1M)(177.7M)
Depreciation1.6B1.6B1.5B1.7B1.9B1.3B
Dividends Paid354.6M351.2M392.5M395.6M454.9M370.4M
Capital Expenditures1.1B1.1B1.1B854.4M724.0M0.0
Net Income1.2B1.2B969.3M673.4M499.0M946.2M
Change To Inventory(117.5M)(355.8M)(48.5M)(204.3M)(183.9M)(193.1M)
Investments(18.0M)(65.1M)(61.6M)(71.3M)(82.0M)(86.1M)
Net Borrowings700.0M(1.6B)(358.9M)(1.0B)(920.7M)(874.7M)
Change To Netincome(173.6M)246.4M32.6M(98.1M)(112.8M)(118.4M)

Fresenius Financial Ratios Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Fresenius Medical's current stock value. Our valuation model uses many indicators to compare Fresenius Medical value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Fresenius Medical competition to find correlations between indicators driving Fresenius Medical's intrinsic value. More Info.
Fresenius Medical Care is rated fourth in return on equity category among its peers. It is number one stock in return on asset category among its peers reporting about  0.51  of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for Fresenius Medical Care is roughly  1.95 . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Fresenius Medical's earnings, one of the primary drivers of an investment's value.

Fresenius Medical Care Systematic Risk

Fresenius Medical's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Fresenius Medical volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was twenty-eight with a total number of output elements of thirty-three. The Beta measures systematic risk based on how returns on Fresenius Medical Care correlated with the market. If Beta is less than 0 Fresenius Medical generally moves in the opposite direction as compared to the market. If Fresenius Medical Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Fresenius Medical Care is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Fresenius Medical is generally in the same direction as the market. If Beta > 1 Fresenius Medical moves generally in the same direction as, but more than the movement of the benchmark.

Fresenius Medical Care Total Assets Over Time

Fresenius Medical Thematic Clasifications

Fresenius Medical Care is part of Drugs investing theme. If you are a theme-oriented, socially responsible, and at the same time, a result-driven investor, you can align your investing habits with your values without jeopardizing your expectations about returns. You can easily create an optimal portfolio of stocks, ETFs, funds, or cryptocurrencies based on a specific theme of your liking. Drug manufacturing and delivery. Companies involved in medical and pharmaceutical drug research, manufacturing, and delivery
DrugsView
This theme covers Drug manufacturing and delivery. Companies involved in medical and pharmaceutical drug research, manufacturing, and delivery. Get More Thematic Ideas

Fresenius Medical December 3, 2024 Opportunity Range

Along with financial statement analysis, the daily predictive indicators of Fresenius Medical help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Fresenius Medical Care. We use our internally-developed statistical techniques to arrive at the intrinsic value of Fresenius Medical Care based on widely used predictive technical indicators. In general, we focus on analyzing Fresenius Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Fresenius Medical's daily price indicators and compare them against related drivers.

Additional Tools for Fresenius Stock Analysis

When running Fresenius Medical's price analysis, check to measure Fresenius Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Fresenius Medical is operating at the current time. Most of Fresenius Medical's value examination focuses on studying past and present price action to predict the probability of Fresenius Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Fresenius Medical's price. Additionally, you may evaluate how the addition of Fresenius Medical to your portfolios can decrease your overall portfolio volatility.